CLINICAL AND MOLECULAR DATA ON MENTAL RETARDATION IN BULGARIA
Todorov T1#, Todorova A1#, Avdjieva D2, Dimova P3, Angelova L4, Tincheva R2 and Mitev V1
*Corresponding Author: Tihomir Todorov, Department of Medical Chemistry and Biochemistry, Sofia Medical University, 2 “Zdrave” str., Sofia 1431, Bulgaria; Tel./Fax: +359 29530715; tisho.todorov@abv.bg
page: 11

PROTOCOLS FOR FMR1 GENE ANALYSIS

Betaine-Based-PCR Protocol. The primers used to amplify the CGG repeat in the 5’UTR of the FMR1 gene, the polymerase chain reaction (PCR) mixture and cycling conditions have been described elsewhere [11]. This amplification permits detection of normal and of some premutated alleles. For the correct sizing, PCR products were subjected to electrophoresis on an ABI PRISM™ 310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) in the presence of ROX500 size standard (Applied Biosystems). Methylation Sensitive MLPA (MSMLPA). The MS-MLPA (SALSA MS-MLPA ME029 probemix) was performed following the manufacturer’s instructions (www.mlpa.com). DNA samples diluted in TE buffer (10 mM Tris- HCl, pH 7.5; 1 mM EDTA) were subjected to denaturation for 10 min. in denaturing buffer provided by the manufacturer. Hybridization with the FMR1-specific probes and 20 control probes was performed overnight at 60°C. Each sample was divided for the ligation reaction, which is the copy number test (CNT) for deletions/duplications detection, and for the ligation-digestion reaction, the methylation test (MT) for methylation assessment at CpG islands. In both tests, the hybridized probes were ligated by a specific ligase mix, provided by the manufacturer. In the methylation, test the methylation-sensitive restriction enzyme HhaI (Pharmacia Biotech, Uppsala, Sweden) was added. The final step consisted of PCR amplification of the obtained fragments. The PCR buffer, PCR primers, the enzyme dilution buffer and the polymerase were provided in the kit. The PCR products obtained were analyzed on an ABI PRISM™ 310 Genetic Analyzer (Applied Biosystems) in the presence of ROX500 size standard (Applied Biosystems). All patient samples were analyzed simultaneously with at least two normal male samples and a mutant male carrier of a full mutation. Copy number changes were determined by comparison to the normal controls. The MT results were easy to interpret as the five FMR1 exon 1 methylation-sensitive fragments (see Figure 1) were absent in the normal controls after HhaI digestion, but were present, as a result of hypermethylation, in a patient carrying a full mutation.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006